Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × INDUSTRY × Neuritis × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 17 Solid Tumor 14 Breast Neoplasms 13 Head and Neck Neoplasms 11 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Sarcoma 10 Neoplasms 10 Pancreatic Neoplasms 9 Melanoma 9 Lymphoma, B-Cell 9 Colorectal Neoplasms 9 Lymphoma 7 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Carcinoma, Non-Small-Cell Lung 7 Burkitt Lymphoma 6 Recurrence 5 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Glioblastoma 5 Carcinoma, Hepatocellular 5 Advanced Solid Tumors 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Osteosarcoma 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Hematologic Neoplasms 4 Glioma 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05291286 2025-01-27

RETRO

Bexion Pharmaceuticals, Inc.

Phase EARLY_PHASE1 Completed

Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡